Trial Profile
A prospective, observational, monocentric, cohort study to evaluate safety of Denosumab in patients underwent kidney transplant
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jul 2017
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Adverse reactions
- 02 Jul 2017 New trial record
- 17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism